Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-02

Clinical Trial Update: Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral Therapy

View source ↗

Summary

A completed CAPRISA study examines tuberculosis recurrence in people receiving highly active antiretroviral therapy (ART) for HIV in South Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antiretroviral therapy

Snippet

Sponsor: Centre for the AIDS Programme of Research in South Africa | Conditions: Tuberculosis | Status: COMPLETED